Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluation of brainstem involvement in multiple sclerosis.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Accelerometry as a measure of walking behavior in multiple sclerosis.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
Progression in multiple sclerosis is associated with low endogenous NCAM.
Natalizumab and monocytes in multiple sclerosis: The dim haze of mystery and the enchantment of pursuit.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
Fast facts: multiple sclerosis.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Role of vitamin D in acquired immune and autoimmune diseases.
Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging.
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
Multiple sclerosis and the blood-central nervous system barrier.
Pages
« first
‹ previous
…
358
359
360
361
362
363
364
365
366
…
next ›
last »